BIOMAT Database Logo BIOMAT Database Logo

[Living attenuated measles-virus vaccine. VI. Results with a killed and living vaccine combination]. 1965

K Murakami, and H Akamatsu, and M Yamamoto, and K Taniguchi, and I Kaneko

UI MeSH Term Description Entries
D007110 Immunity, Active Resistance to a disease agent resulting from the production of specific antibodies by the host, either after exposure to the disease or after vaccination. Active Immune Response,Active Immune Responses,Active Immunities,Active Immunity,Immune Response, Active,Immune Responses, Active,Immunities, Active,Response, Active Immune,Responses, Active Immune
D008297 Male Males
D008457 Measles A highly contagious infectious disease caused by MORBILLIVIRUS, common among children but also seen in the nonimmune of any age, in which the virus enters the respiratory tract via droplet nuclei and multiplies in the epithelial cells, spreading throughout the MONONUCLEAR PHAGOCYTE SYSTEM. Rubeola
D008458 Measles Vaccine A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had measles or been immunized with live measles vaccine and have no serum antibodies against measles. Children are usually immunized with measles-mumps-rubella combination vaccine. (From Dorland, 28th ed) Vaccine, Measles
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

K Murakami, and H Akamatsu, and M Yamamoto, and K Taniguchi, and I Kaneko
[Living attenuated measles-virus vaccine. IV. Serological response of children before and after immunization with a living measles-virus vaccine].
January 1965, Nihon Ika Daigaku zasshi,
K Murakami, and H Akamatsu, and M Yamamoto, and K Taniguchi, and I Kaneko
[Living attenuated measles-virus vaccine. V. Protective affects and persistent immunity after inoculation with a living measles vaccine].
January 1965, Nihon Ika Daigaku zasshi,
K Murakami, and H Akamatsu, and M Yamamoto, and K Taniguchi, and I Kaneko
Killed-measles-virus vaccine.
August 1967, Lancet (London, England),
K Murakami, and H Akamatsu, and M Yamamoto, and K Taniguchi, and I Kaneko
KILLED MEASLES-VIRUS VACCINE.
December 1963, New York state journal of medicine,
K Murakami, and H Akamatsu, and M Yamamoto, and K Taniguchi, and I Kaneko
MEASLES VACCINE: RESULTS OF STUDIES WITH BOTH KILLED AND LIVE VIRUS VACCINE.
July 1964, Memphis and Mid-South medical journal,
K Murakami, and H Akamatsu, and M Yamamoto, and K Taniguchi, and I Kaneko
Experience with measles immunization. Alum-absorbed killed measles-virus vaccine and live measles-virus vaccine challenge.
March 1962, American journal of diseases of children (1960),
K Murakami, and H Akamatsu, and M Yamamoto, and K Taniguchi, and I Kaneko
INACTIVATED MEASLES VIRUS VACCINE SUBSEQUENTLY CHALLENGED WITH LIVE ATTENUATED MEASLES VIRUS VACCINE.
February 1965, Japanese journal of medical science & biology,
K Murakami, and H Akamatsu, and M Yamamoto, and K Taniguchi, and I Kaneko
Use of living attenuated measles-virus vaccine in early infancy.
August 1960, The New England journal of medicine,
K Murakami, and H Akamatsu, and M Yamamoto, and K Taniguchi, and I Kaneko
Combination of attenuated measles vaccine (Schwarz) with meningococcus A and A + C vaccine.
January 1978, Developments in biological standardization,
K Murakami, and H Akamatsu, and M Yamamoto, and K Taniguchi, and I Kaneko
MEASLES VACCINE FIELD TRIALS IN ALASKA. I. KILLED VACCINE FOLLOWED BY LIVE ATTENUATED VACCINE AND GAMMA-GLOBULIN WITH LIVE ATTENUATED VACCINE.
August 1964, JAMA,
Copied contents to your clipboard!